Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

By F. Toledo, G. Wahl. Nature Reviews. Cancer, 2006

1,369 citations recorded by the source corpus.

Subfields: Biotechnology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/5da755ccb5d223d31abe843842eff1e3d6b76a7f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biotechnology

1. D. Meek
2. Carol Prives
3. Karen H. Vousden

In Molecular Biology

1. Xiang-Jiao Yang
2. Carol Prives
3. D. Meek
4. E. Seto
5. Karen H. Vousden
6. Vladimir N Uversky
7. W. Gu

In Oncology

1. Carol Prives
2. D. Meek
3. Karen H. Vousden
4. E. Seto
5. Xiang-Jiao Yang
6. Vladimir N Uversky
7. W. Gu

Citations in the corpus

• Tumour suppression by p53: a role for the DNA damage response? (2009, background): “The induction and activation of p53 p53 is stabilized and activated in response to a range of cellular stresses, including DNA damage and hyperproliferatio”
• Blinded by the Light: The Growing Complexity of p53. (2009, background): “A wealth of studies have delved into their interactions with p53 and have been well reviewed (Marine et al., 2006, 2007; Poyurovsky and Prives, 2006; Toledo and Wahl, 2006).”
• Lysine acetylation: codified crosstalk with other posttranslational modifications (2008, background): “As the acetylation sites are conserved between human and mouse p53 (Figure 3A), two groups have investigated this issue using knockin mice (Toledo and Wahl, 2006).”